V
ValGenesis
Paperless Validation Software for Life Sciences Companies
About ValGenesis
Founded in 2005 by Dr. Siva Samy, ValGenesis provides digital transformation solutions for the life sciences industry, focusing on automating validation processes to ensure regulatory compliance and increase efficiency. Dr. Samy, who serves as CEO and Chief Product Strategist, identified the inefficiencies and compliance risks of paper-based validation systems after holding various technical and management roles in biotech, pharmaceutical, and medical device companies. His vision was to create a single, fully digital lifecycle process to replace the fragmented, multi-system approach, leading to the development of the industry's first 100% paperless Validation Lifecycle Management System (VLMS). Dr. Samy holds a Ph.D. in Medical Devices and a patent for validating and maintaining the validation status of software and manufacturing systems.
ValGenesis operates on a software-as-a-service (SaaS) business model, offering its cloud-based platform to pharmaceutical, biotechnology, and medical device organizations. The company generates revenue through subscriptions to its software suites and by providing professional services such as implementation, training, and consulting. Its clients include 30 of the top 50 global life sciences companies, who use the platform to manage validation activities, thereby reducing costs and validation cycle times by up to 50%. The company has demonstrated significant growth, reporting a 68% year-over-year revenue increase for the fiscal year ending in early 2022.
The core offering is the ValGenesis VLMS, an end-to-end platform that digitizes the entire validation lifecycle, from planning and execution to reporting and archiving. The platform ensures compliance with regulations like FDA 21 CFR Part 11 and EU Annex 11. The product portfolio has expanded significantly, notably through the 2022 acquisition of 4Tune Engineering, which added advanced risk management and continuous process verification capabilities. ValGenesis's suite now includes specialized, AI-enabled modules like iVal for computer system validation and qualification, iClean for digitizing cleaning validation, and iRisk for risk management. In July 2025, the company launched ValGenesis Smart GxP, an AI-powered platform designed to unify validation and process lifecycle management. To cater to smaller firms, ValGenesis introduced "VLMS Express," a pre-configured, rapidly deployable version of its enterprise system.
Source: Dealroom company dataAt a glance
- Founded
- 2005
- Headquarters
- Santa Clara, United States
- Sector
- Other B2B Software
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Lighter Capital
Morgan Stanley
Morgan Stanley Expansion Capital
Bridge Bank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ValGenesis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ValGenesis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.